Cyclosporin neurotoxicity in cardiac transplant recipients.

AUTOR(ES)

Lane, R J

RESUMO

Cyclosporin toxicity may produce a wide range of neurological disorders. We report three patients whose neurological problems developed while taking cyclosporin following cardiac transplantation, but resolved rapidly when the drug was discontinued. In two cases, MRI revealed abnormalities which disappeared with clinical recovery. Blood cyclosporin concentrations were not markedly increased, and it is possible that the neurotoxic effects of cyclosporin are mediated by metabolites, through an effect on the blood-brain barrier.

Documentos Relacionados

• Cyclosporin neurotoxicity in cardiac transplant recipient.
• Surveillance cardiac catheterisation in heart transplant recipients.
• Current management of cardiac transplant recipients.
• Raised concentrations of plasma atrial natriuretic peptides in cardiac transplant recipients.
• Vascular remodelling in intramyocardial resistance vessels in hypertensive human cardiac transplant recipients.